Can multi-criteria decision analysis be implemented into real world drug decision-making processes? A Canadian provincial experience

7 August 2020 - This paper describes the implementation of multi-criteria decision analysis into a Canadian public drug reimbursement decision-making process, ...

Read more →

Return some excess drug revenues to employers, CLHIA says in submission to PMPRB

10 August 2020 - In its submission to the Patented Medicine Prices Review Board’s draft guidelines, the Canadian Life and ...

Read more →

B.C. family nearing finish in race to raise $2.8 million to treat baby's rare disease

8 August 2020 - Parents hope funds will pay for expensive therapy not approved in Canada for type 1 spinal muscular ...

Read more →

Catalyst Pharmaceuticals’ Firdapse (amifampridine phosphate) receives marketing approval in Canada for patients with LEMS

6 August 2020 - Catalyst Pharmaceuticals today announced that Canada’s national health care regulatory agency, Health Canada, has approved the ...

Read more →

Canada inks deals with Pfizer, Moderna for coronavirus vaccine candidates

5 August 2020 - The Canadian government has signed new deals with pharmaceutical firms Pfizer and Moderna to secure millions ...

Read more →

Janssen announces Health Canada approval of Darzalex SC, a new subcutaneous formulation for the treatment of patients with multiple myeloma

4 August 2020 - Darzalex SC reduces administration time from hours to minutes and demonstrates consistent efficacy with a reduction in ...

Read more →

Innovative Medicines Canada responds to the revised draft PMPRB Guidelines consultation

4 August 2020 - The Patented Medicine Prices Review Board's revised Guidelines will result in patients losing access to innovative ...

Read more →

Health Canada Approves Brivlera (brivaracetam) to treat partial-onset seizures in paediatric epilepsy patients

29 July 2020 - Health Canada's approval of Brivlera provides paediatric epilepsy patients with a treatment option which can be initiated ...

Read more →

CADTH publishes final recommendation for a new combination product for HIV infection

24 July 2020 - Cabenuva (cabotegravir and rilpivirine extended release injectable suspensions) is indicated as a complete regimen for the treatment ...

Read more →

Health Canada grants marketing authorisation with conditions for Gilead's Veklury (remdesivir) for the treatment of coronavirus disease 2019 (COVID-19)

28 July 2020 - Veklury is the first approved treatment option for COVID-19 in Canada. ...

Read more →

CADTH posts final recommendation for Aimovig

26 July 2020 - Final recommendation informed by input from Migraine Canada and Migraine Quebec. ...

Read more →

'I need something to move forward,' says Edmonton mom waiting for approval for son's life saving treatment

24 July 2020 - The family of a little boy in need of a $3 million treatment says they have ...

Read more →

CADTH publishes final recommendation for Mayzent

23 July 2020 - The recommendation relates to the use of siponomid for the treatment of patients with secondary progressive multiple ...

Read more →

Spravato (esketamine) nasal spray is available for Canadian patients

22 July 2020 - A new anti-depressant with a novel mechanism of action to treat major depressive disorder in adults. ...

Read more →

Pandemic creating potential for drug shortages that Canada isn't equipped to deal with

22 July 2020 - Canada needs to become self-reliant in developing and supplying its own critical drugs, vaccines. ...

Read more →